Nintedanib in patients with progressive fibrosing...

  • Main
  • 2020 / 3
  • Nintedanib in patients with progressive fibrosing...
The Lancet Respiratory Medicine 2020 / 3

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Wells, Athol U, Flaherty, Kevin R, Brown, Kevin K, Inoue, Yoshikazu, Devaraj, Anand, Richeldi, Luca, Moua, Teng, Crestani, Bruno, Wuyts, Wim A, Stowasser, Susanne, Quaresma, Manuel, Goeldner, Rainer-G
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Respiratory Medicine
DOI:
10.1016/S2213-2600(20)30036-9
Date:
March, 2020
File:
PDF, 456 KB
2020
Conversion to is in progress
Conversion to is failed